What are the EULAR recommendations for the management of large vessel vasculitis?
The 2018 Update of the EULAR recommendations for the management of large vessel vasculitis, published in Annals of Rheumatic Diseases in 2020, recommend that patients should be treated with high doses of corticosteroids and immunosuppressants, supplemented with other drugs such as methotrexate, azathioprine, or cyclophosphamide, depending on the individual's condition. Other therapies, such as rituximab, tocilizumab, and anakinra, are also recommended in certain cases.  Surgery may be necessary for certain cases of large vessel vasculitis. In addition, lifestyle modifications, such as smoking cessation and regular exercise, should be encouraged.